Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

SANUWAVE Health Stock News

SNWVNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$38.00

0.000.00%

Pre-Market: 4:00 PM EDT

Q4 2024 Earnings were released on Thu Mar 20th, after the market close

The most recent conference call was at 8:30 AM, 5 days ago Click to view past webcast

SANUWAVE Health (SNWV) Forecast

News

Earnings SANUWAVE Health (SNWV) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest SANUWAVE Health Stock News | NASDAQ:SNWV | Benzinga

Get the latest news on SANUWAVE Health stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on SANUWAVE Health performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, March 21, 2025

SANUWAVE Health shares are trading higher aft...
Benzinga Newsdesk
SANUWAVE Health Q4 Sales $10.326M Up From $6....
Benzinga Newsdesk

Thursday, March 20, 2025

Earnings Scheduled For March 20, 2025
Benzinga Insights

Tuesday, March 04, 2025

Sanuwave Health To Uplist To The Nasdaq Globa...
Benzinga Newsdesk

Thursday, November 07, 2024

SANUWAVE Health Q3 EPS $(6.49) Up From $(9.95...
Benzinga Newsdesk

Tuesday, September 15, 2020

Lake Street Initiates Coverage On SANUWAVE He...
Benzinga Newsdesk

Tuesday, March 24, 2020

Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights

Friday, February 21, 2020

Stocks That Hit 52-Week Highs On Friday
Lisa Levin

Thursday, February 20, 2020

Stocks That Hit 52-Week Highs On Thursday
Lisa Levin

Tuesday, February 18, 2020

Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin

Thursday, February 13, 2020

Stocks That Hit 52-Week Highs On Thursday
Lisa Levin

Wednesday, February 12, 2020

Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin

Tuesday, December 17, 2019

SNWV: U.S. Roll-Out May Be Stronger Than Previously Anticipated
Zacks Small Cap Research

Tuesday, May 21, 2019

SANUWAVE HEALTH INC by SANUWAVE Health, Inc. ...
Benzinga Newsdesk

Wednesday, May 16, 2018

SANUWAVE HEALTH INC by SANUWAVE Health, Inc. Q1 EPS $(0.04), Made $344.272K Sales
Benzinga

Monday, August 14, 2017

Sanuwave Health Reports Q2 EPS $(0.01) vs. $(...
Benzinga

Wednesday, July 13, 2011

Rodman & Renshaw Reiterates Market Outperform and PT of $6 on Sanuwave Health
Benzinga

Tuesday, July 12, 2011

SANUWAVE Announces Positive 24-Week Data from Its Pivotal Trial with dermaPACE for the Treatment of Diabetic Foot Ulcers
Benzinga

Wednesday, July 06, 2011

SANUWAVE Health Submits Final Module of PMA Application for FDA Approval of dermaPACE
Benzinga

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved